OLN241115C52500
- 0.10
- 0.000.00%
Olin Newsroom
Olin Corporation (NYSE:OLN) Will Pay A US$0.20 Dividend In Three Days
FBI Firearm Background Checks Track Higher Ahead of the U.S. Election
Piper Sandler Maintains Olin(OLN.US) With Buy Rating, Cuts Target Price to $51
Olin Is Maintained at Market Perform by BMO Capital
Olin Biology (688319.SH): The proposed additional fundraising will not exceed 0.3 billion yuan.
On October 29, Gelonhui announced that Olin Biotech (688319.SH) disclosed that the total amount of funds raised by the company in this issuance of stocks shall not exceed 175.2929 million yuan (including this amount), not more than 0.3 billion yuan and not more than 20% of the net assets at the end of the most recent year. The net proceeds from the funds raised after deducting the relevant issuance expenses are intended to be invested in the following project: the technical renovation project of the vaccine R&D production base.
Morgan Stanley Maintains Olin(OLN.US) With Sell Rating, Maintains Target Price $41
Express News | Olin Corp : BMO Cuts Target Price to $47 From $50
RBC Capital Maintains Olin(OLN.US) With Buy Rating, Cuts Target Price to $48
Olin Biosciences (688319.SH): The net income in the first three quarters was 4.0259 million yuan, a year-on-year decrease of 86.71%.
Gelonghui October 29th news｜Olin Biology (688319.SH) announced the third quarter report of 2024, the company's revenue for the first three quarters of the year was 0.387 billion yuan, a year-on-year increase of 9.75%; net income attributable to shareholders of listed companies was 4.0259 million yuan, a year-on-year decrease of 86.71%; basic earnings per share were 0.0099 yuan.
Evaluating Olin: Insights From 6 Financial Analysts
Olin Analysts Slash Their Forecasts After Q3 Earnings
BofA Securities Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $48
Olin Price Target Cut to $56.00/Share From $57.00 by Keybanc
Olin Is Maintained at Overweight by Keybanc
Keybanc Maintains Overweight on Olin, Lowers Price Target to $56
Olin Analyst Ratings
A Quick Look at Today's Ratings for Olin(OLN.US), With a Forecast Between $44 to $56
The Total Return for Olin (NYSE:OLN) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
Express News | Olin : Deutsche Bank Cuts Target Price to $45 From $48
Analysts Conflicted on These Materials Names: Olin (OLN), First Quantum Minerals (OtherFQVLF) and Vale SA (VALE)